GLP-1 Analogue and Medication Review Optimisation

PCN Pro-Forma - Norfolk & Waveney

In response to the national shortage of GLP-1 analogues, ECLIPSE (Equality of Care Led Insights for Patient Safety & Engagement), in collaboration with your ICB, is implementing a GLP-1 and medicines optimisation project, which aims to engage with patients on GLP-1 analogues, to:

Identify those with a genuine indication or need for this class of medication.
Where indicated, to ensure that patients have adequate supply of their GLP-1 analogues.
Evaluate patients for which GLP-1s may no longer be indicated, or where they could safely move to an alternative medication.
Obtain patient consent to consider stopping or changing their GLP-1 medication.
To provide significant cost-savings to the NHS.

This pathway aims to gather important patient information around their diabetes management, empower patient-led care while safely addressing the national medication shortage.

Additionally, the CQC-accredited Putting Patient's First team will use this opportunity to conduct holistic structured medication reviews to optimise patient safety through appropriate and agreed medication changes.

Please complete the pro forma below to provide PCN consent for this programme.

PCN Name

Name of your GP Practice(s), within your PCN, who have agreed to participate in this programme:

(if known, please add the national practice code for each practice)

Programme Activation

(Please tick to confirm your practice activation for the programme below):

GLP-1 Analogue and Medication Review Optimisation

PEGASUS – Patient Engagement Governance-Assured Supporting the Use of Services

A new approach to patient engagement is available which can automatically identify and engage with eligible patients, educating and consenting them for optimisations.

Contacting Patients

1. Are the practices happy for patients within the activated cohort to be contacted by the Eclipse automated patient engagement interface? (NB: this will involve SMS messaging):

Yes

2. Are the practices happy for patients within the activated cohort to be contacted by a patient engagement team? (NB: this will involve telephone calls):

Yes

Reviewing Patients:

3. Are the practices happy for patients to have a holistic structured medication review completed by the Putting Patients First Team?:

Yes

4. Are the practices happy for patients to receive a feedback questionnaire for evaluation of the programme and to allow them to express any preferences with the switches?:

Yes

Key Contacts (required)

PCN Admin Lead:

First Name

Last Name

NHS Email

PCN Clinical Director:

First Name

Last Name

NHS Email

Please note that these preferences can be changed in the future. Your listed surgeries will be contacted to gain explicit consent to contact and review their patients prior to any patient engagement.

GLP-1 Analogue and Medication Review Optimisation

Eclipse Partnership Programme